Loading...

ZNF423: A New Player in Estrogen Receptor-Positive Breast Cancer

Preventive therapy can target hormone-responsive breast cancer (BC) by treatment with selective estrogen receptor modulators (SERMs) and reduce the incidence of BC. Genome-wide association studies have identified single nucleotide polymorphisms (SNPs) with relevant predictive values, SNPs in the ZNF...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Front Endocrinol (Lausanne)
Main Authors: Bond, Heather M., Scicchitano, Stefania, Chiarella, Emanuela, Amodio, Nicola, Lucchino, Valeria, Aloisio, Annamaria, Montalcini, Ylenia, Mesuraca, Maria, Morrone, Giovanni
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5968090/
https://ncbi.nlm.nih.gov/pubmed/29867779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00255
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!